Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
J Hosp Infect ; 143: 38-47, 2024 01.
Article in English | MEDLINE | ID: mdl-38295006

ABSTRACT

BACKGROUND: Between 2018 and 2022, a Belgian tertiary care hospital faced a growing issue with acquiring carbapenemase-producing organisms (CPO), mainly VIM-producing P. aeruginosa (PA-VIM) and NDM-producing Enterobacterales (CPE-NDM) among hospitalized patients in the adult intensive care unit (ICU). AIM: To investigate this ICU long-term CPO outbreak involving multiple species and a persistent environmental reservoir. METHODS: Active case finding, environmental sampling, whole-genome sequencing (WGS) analysis of patient and environmental strains, and implemented control strategies were described in this study. FINDINGS: From 2018 to 2022, 37 patients became colonized or infected with PA-VIM and/or CPE-NDM during their ICU stay. WGS confirmed the epidemiological link between clinical and environmental strains collected from the sink drains with clonal strain dissemination and horizontal gene transfer mediated by plasmid conjugation and/or transposon jumps. Environmental disinfection by quaternary ammonium-based disinfectant and replacement of contaminated equipment failed to eradicate environmental sources. Interestingly, efflux pump genes conferring resistance to quaternary ammonium compounds were widespread in the isolates. As removing sinks was not feasible, a combination of a foaming product degrading the biofilm and foaming disinfectant based on peracetic acid and hydrogen peroxide has been evaluated and has so far prevented recolonization of the proximal sink drain by CPO. CONCLUSION: The persistence in the hospital environment of antibiotic- and disinfectant-resistant bacteria with the ability to transfer mobile genetic elements poses a serious threat to ICU patients with a risk of shifting towards an endemicity scenario. Innovative strategies are needed to address persistent environmental reservoirs and prevent CPO transmission.


Subject(s)
Cross Infection , Disinfectants , Adult , Humans , Cross Infection/epidemiology , Cross Infection/prevention & control , beta-Lactamases/genetics , Bacterial Proteins/genetics , Disease Outbreaks , Anti-Bacterial Agents , Intensive Care Units
2.
J Cyst Fibros ; 19(6): 872-874, 2020 11.
Article in English | MEDLINE | ID: mdl-32828701

ABSTRACT

BACKGROUND: In Belgium, COVID-19 epidemy began on February 4, 2020 with a peak on April 10, 2020. Patients with cystic fibrosis (CF) followed in the Cliniques universitaires Saint-Luc were rapidly isolated before the government lockdown. METHODS: After the peak of the epidemy, we measured anti-SARS-CoV-2 IgM and IgG antibodies in 149 patients and collected clinical data. RESULTS: Only 3 asymptomatic patients presented IgG against the virus. In one patient hospitalized for COVID-19 (positive molecular testing), we did not detect any anti-SARS-CoV-2 antibodies, as in thirty-five other symptomatic patients considered as possible cases. CONCLUSIONS: Even if respiratory symptoms linked to CF are frequent and compatible with COVID-19, anti-SARS-CoV-2 IgG antibodies were detected only in 3 asymptomatic patients. This reassuring study concerning the risk of COVID-19 in patients with CF illustrates the difficulty to distinguish COVID-19 symptoms from respiratory exacerbations and the need of generalized molecular testing to make a precise diagnosis.


Subject(s)
Antibodies, Viral/analysis , COVID-19 , Communicable Disease Control/methods , Cystic Fibrosis , SARS-CoV-2 , Adult , Asymptomatic Infections/epidemiology , Belgium/epidemiology , COVID-19/epidemiology , COVID-19/immunology , COVID-19/prevention & control , COVID-19/therapy , COVID-19 Serological Testing/methods , COVID-19 Serological Testing/statistics & numerical data , Cystic Fibrosis/diagnosis , Cystic Fibrosis/epidemiology , Diagnosis, Differential , Female , Hospitalization/statistics & numerical data , Humans , Male , Outcome Assessment, Health Care , Risk Assessment , SARS-CoV-2/immunology , SARS-CoV-2/isolation & purification , Seroepidemiologic Studies
3.
Anaerobe ; 49: 95-98, 2018 Feb.
Article in English | MEDLINE | ID: mdl-29325875

ABSTRACT

We report the case of a 69-year-old man admitted for septic shock secondary to necrotic pneumoniae complicated by thoracic empyema of fatal issue. Microbiological examination of pleural liquid revealed a mixed anaerobic flora involving Campylobacter rectus and Actinomyces meyeri. Campylobacter rectus is an infrequent anaerobic pathogen of oral origin To our knowledge, this is the first case report of fatal C. rectus - associated thoracic empyema, and only the second reported case in which identification was successfully performed by MALDI-TOF MS.


Subject(s)
Campylobacter Infections/microbiology , Campylobacter rectus/physiology , Empyema, Pleural/microbiology , Aged , Anti-Bacterial Agents/administration & dosage , Campylobacter Infections/drug therapy , Campylobacter Infections/mortality , Campylobacter rectus/drug effects , Campylobacter rectus/genetics , Campylobacter rectus/isolation & purification , Empyema, Pleural/drug therapy , Empyema, Pleural/mortality , Fatal Outcome , Humans , Male
4.
Eur J Clin Microbiol Infect Dis ; 34(2): 405-13, 2015 Feb.
Article in English | MEDLINE | ID: mdl-25252627

ABSTRACT

Speeding up the turn-around time of positive blood culture identifications is essential in order to optimize the treatment of septic patients. Several sample preparation techniques have been developed allowing direct matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) identification of positive blood cultures. Yet, the hands-on time restrains their routine workflow. In this study, we evaluated an approach whereby MALDI-TOF MS identification without any additional steps was carried out on short subcultured colonies from positive blood bottles with the objective of allowing results reporting on the day of positivity detection. Over a 7-month period in 2012, positive blood cultures detected by 9 am with an automated system were inoculated onto a Columbia blood agar and processed after a 5-h incubation on a MALDI-TOF MicroFlex platform (Bruker Daltonik GmbH). Single-spotted colonies were covered with 1 µl formic acid and 1 µl matrix solution. The results were compared to the validated identification techniques. A total of 925 positive blood culture bottles (representing 470 bacteremic episodes) were included. Concordant identification was obtained in 727 (81.1 %) of the 896 monomicrobial blood cultures, with failure being mostly observed with anaerobes and yeasts. In 17 episodes of polymicrobic bacteremia, the identification of one of the two isolates was achieved in 24/29 (82.7 %) positive cultures. Routine implementation of MALDI-TOF MS identification on young positive blood subcultures provides correct results to the clinician in more than 80 % of the bacteremic episodes and allows access to identification results on the day of blood culture positivity detection, potentially accelerating the implementation of targeted clinical treatments.


Subject(s)
Bacteremia/diagnosis , Gram-Negative Bacteria/isolation & purification , Gram-Positive Bacteria/isolation & purification , Sepsis/diagnosis , Specimen Handling/methods , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization/methods , Bacteremia/microbiology , Culture Media , Formates , Humans , Mass Spectrometry , Sepsis/microbiology , Time Factors
5.
Clin Microbiol Infect ; 20(1): 44-50, 2014 Jan.
Article in English | MEDLINE | ID: mdl-23586637

ABSTRACT

During an 8-month period, 24 Corynebacterium striatum isolates recovered from lower respiratory tract specimens of 10 hospitalized patients were characterized. The organisms were identified by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) and by 16S rRNA gene sequencing. The cluster of C. striatum exclusively affected patients who had been admitted to an intensive care unit and/or subsequently transferred to one medium-size respiratory care unit. Prolonged duration of hospitalization, advanced stage of chronic obstructive pulmonary disease, recent administration of antibiotics and exposure to an invasive diagnostic procedure were the most commonly found risk factors in these patients. Seven patients were colonized and three infected. All strains displayed a similar broad spectrum resistance to antimicrobial agents, remaining susceptible to vancomycin only. Typing analysis by MALDI-TOF MS and by semi-automated repetitive sequence-based PCR (DiversiLab typing) showed that all outbreak-associated C. striatum isolates clustered together in one single type while they differed markedly from epidemiologically unrelated C. striatum isolates. Pulsed-field gel electrophoresis (PFGE) profiles revealed three distinct PFGE types among the C. striatum isolates associated with the outbreak while all external strains except one belonged to a distinct type. We conclude that C. striatum is an opportunistic nosocomial pathogen in long-term hospitalized patients and can be at the origin of major outbreaks. The routine use of MALDI-TOF MS greatly facilitated the recognition/identification of this organism in clinical samples and this technique could also offer the potential to be used as an easy and rapid epidemiological typing tool for outbreak investigation.


Subject(s)
Corynebacterium Infections/epidemiology , Corynebacterium/isolation & purification , Cross Infection/epidemiology , Disease Outbreaks , Drug Resistance, Multiple, Bacterial/genetics , Aged , Aged, 80 and over , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/therapeutic use , Bacterial Typing Techniques , Belgium , Corynebacterium/classification , Corynebacterium/drug effects , Corynebacterium/genetics , Corynebacterium Infections/microbiology , Cross Infection/drug therapy , Cross Infection/microbiology , Hospitals, University , Humans , Male , Middle Aged , RNA, Bacterial/genetics , RNA, Ribosomal, 16S/genetics , Risk Factors , Sequence Analysis, RNA , Vancomycin/pharmacology , Vancomycin/therapeutic use
6.
Eur J Clin Microbiol Infect Dis ; 32(10): 1341-5, 2013 Oct.
Article in English | MEDLINE | ID: mdl-23670277

ABSTRACT

Puumala virus (PUUV) is considered a classic Old World etiologic agent of nephropathia epidemica (NE), or hemorrhagic fever with renal syndrome (HFRS). HFRS is considered to be distinct from hantavirus (cardio-)pulmonary syndrome (HPS or HCPS), described in the New World. Here, we report a severe case, which fulfilled most, if not all, Centers for Disease Control and Prevention (CDC) criteria for HPS, needing non-invasive ventilation and subsequent acute hemodialysis. However, the etiological agent was PUUV, as proved by serological testing, real-time polymerase chain reaction (PCR), and sequencing. Viral antigen was detected by specific anti-PUUV immunostaining, showing, for the first time, greenish intracytoplasmic inclusions in bronchoalveolar lavage (BAL) macrophages. This case definitely confirms that HPS can be encountered during PUUV infections. Interestingly, special findings could render the diagnosis easier, such as greenish homogeneous cytoplasmic inclusions, surrounded by a fine clear halo in BAL macrophages. Therefore, although the diagnosis remains difficult before the onset of renal involvement, the occurrence of severe respiratory failure mimicking community-acquired pneumonia must alert the clinician for possible HPS, especially in endemic areas.


Subject(s)
Hantavirus Pulmonary Syndrome/complications , Hantavirus Pulmonary Syndrome/diagnosis , Hemorrhagic Fever with Renal Syndrome/diagnosis , Inclusion Bodies, Viral , Lung/virology , Macrophages, Alveolar/virology , Puumala virus/isolation & purification , Adult , Bronchoalveolar Lavage Fluid/cytology , Bronchoalveolar Lavage Fluid/virology , Cluster Analysis , Female , Humans , Phylogeny , Puumala virus/classification , Puumala virus/genetics , Radiography, Thoracic , Real-Time Polymerase Chain Reaction , Sequence Analysis, DNA , Serotyping , Tomography, X-Ray Computed
7.
Acta Clin Belg ; 67(4): 286-91, 2012.
Article in English | MEDLINE | ID: mdl-23019805

ABSTRACT

BACKGROUND: Recommendations were applied before and during the Belgian pandemic (2009) H1N1 influenza wave at a university hospital (420 beds), for optimizing isolation processes and therapeutic management of possible and confirmed infected cases. METHODS: All patients presenting to the Emergency Department (ED) between August 1st and December 31st 2009 were screened for ILI symptoms, and were isolated for clinical assessment in case of positive screening. Patients categorized as possible influenza cases and who required hospitalization were isolated in dedicated wards. Specific diagnostic algorithms were implemented. Medical charts were retrospectively reviewed and matched with results of the microbiology laboratory. Patient's characteristics were analyzed, the contribution of laboratory diagnosis on therapy and lengh of stay (LOS) in isolation was also assessed. RESULTS: 310 patients out of 6068 had a positive screening for ILI, of these, 265 were retained as possible influenza cases and 139 required hospitalization. Twenty-eight children (8 requiring hospitalization) and 20 hospitalized adult patients had confirmed influenza infection. Five adult patients were admitted to the intensive care unit (ICU), 3 requiring extracorporeal membrane oxygenation (ECMO). There was no death related to the new influenza strain. The majority of confirmed patients were diagnosed during the Belgian epidemic wave, with a sensitivity of antigen detection of 50% in children and 35% in adults comparatively to real-time PCR (RT-PCR). CONCLUSIONS: The impact of (2009) H1N1 pandemic influenza remained limited, except for ICU patients requiring ECMO. Implementation of screening, isolation, and virological diagnosis processes led to significant improvement of patient management.


Subject(s)
Influenza A Virus, H1N1 Subtype , Influenza, Human/epidemiology , Pandemics , Adolescent , Adult , Aged , Aged, 80 and over , Belgium/epidemiology , Child , Child, Preschool , Hospitalization , Hospitals, University , Humans , Infant , Influenza, Human/diagnosis , Influenza, Human/therapy , Influenza, Human/virology , Middle Aged , Young Adult
8.
J Clin Microbiol ; 48(11): 4015-21, 2010 Nov.
Article in English | MEDLINE | ID: mdl-20861335

ABSTRACT

The identification of Nocardia species, usually based on biochemical tests together with phenotypic in vitro susceptibility and resistance patterns, is a difficult and lengthy process owing to the slow growth and limited reactivity of these bacteria. In this study, a panel of 153 clinical and reference strains of Nocardia spp., altogether representing 19 different species, were characterized by matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS). As reference methods for species identification, full-length 16S rRNA gene sequencing and phenotypical biochemical and enzymatic tests were used. In a first step, a complementary homemade reference database was established by the analysis of 110 Nocardia isolates (pretreated with 30 min of boiling and extraction) in the MALDI BioTyper software according to the manufacturer's recommendations for microflex measurement (Bruker Daltonik GmbH, Leipzig, Germany), generating a dendrogram with species-specific cluster patterns. In a second step, the MALDI BioTyper database and the generated database were challenged with 43 blind-coded clinical isolates of Nocardia spp. Following addition of the homemade database in the BioTyper software, MALDI-TOF MS provided reliable identification to the species level for five species of which more than a single isolate was analyzed. Correct identification was achieved for 38 of the 43 isolates (88%), including 34 strains identified to the species level and 4 strains identified to the genus level according to the manufacturer's log score specifications. These data suggest that MALDI-TOF MS has potential for use as a rapid (<1 h) and reliable method for the identification of Nocardia species without any substantial costs for consumables.


Subject(s)
Bacteriological Techniques/methods , Nocardia/chemistry , Nocardia/isolation & purification , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization/methods , Bacterial Typing Techniques , DNA, Bacterial/chemistry , DNA, Bacterial/genetics , DNA, Ribosomal/chemistry , DNA, Ribosomal/genetics , Germany , Humans , Nocardia/classification , Nocardia Infections/diagnosis , Nocardia Infections/microbiology , RNA, Ribosomal, 16S/genetics , Sensitivity and Specificity , Sequence Analysis, DNA
SELECTION OF CITATIONS
SEARCH DETAIL
...